Blepharoplasty (Eyelid Surgery) in India and UAE | Complete Patient Guide

Ideal Candidates — Medical Eligibility:

• Adults (typically ≥35 years) with documented dermatochalasis causing superior visual field loss ≥12–30% on Humphrey 24-2 or 30-2 perimetry (functional indication)

• Patients with cosmetic concerns: bilateral upper or lower lid hooding, periorbital fat prolapse, or lower lid festoons that are refractory to non-surgical management

• Individuals with congenital or acquired blepharoptosis (MRD1 < 2 mm) requiring concurrent levator advancement or Müller's muscle-conjunctival resection (MMCR)

• Patients seeking Asian double-eyelid creation (suture or incision technique) or revision of a prior blepharoplasty with asymmetry or scar contracture

• Candidates with realistic expectations, adequate tear film reserve (Schirmer's I ≥ 10 mm/5 min), and positive Bell's phenomenon

Required Pre-Operative Diagnostics:

• Complete ophthalmic examination: best-corrected visual acuity (BCVA), slit-lamp biomicroscopy, intraocular pressure (IOP)

• Eyelid measurements: MRD1, MRD2, levator excursion, upper sulcus depth, lower scleral show

• Automated visual field testing (Humphrey perimetry) with and without lid tape — mandatory for functional/insurance cases

• Schirmer's test (tear secretion) and TBUT (tear film stability) to rule out dry eye disease

• High-resolution standardised periorbital photography (minimum 6 views) for surgical planning

• Thyroid function tests (TSH, Free T4) and thyroid peroxidase antibodies to exclude thyroid eye disease (TED)

• Coagulation profile (PT, aPTT, INR), full blood count, metabolic panel

• Blood pressure assessment — hypertension significantly increases intraoperative bleeding risk

• For patients ≥50 years or with cardiac history: ECG and anaesthesiologist pre-assessment

Contraindications:

• Active thyroid eye disease (Graves' orbitopathy) in the inflammatory phase — surgery is deferred until CAS (Clinical Activity Score) ≤ 1 for ≥6 months

• Severe dry eye syndrome (Schirmer's I < 5 mm/5 min) or corneal exposure keratopathy — relative contraindication requiring optimisation

• Negative Bell's phenomenon with poor corneal sensation — high risk of post-operative exposure keratitis

• Active ocular infection or uncontrolled glaucoma

• Bleeding diatheses or anticoagulant therapy that cannot be safely bridged (e.g., warfarin, novel oral anticoagulants, clopidogrel)

• Unrealistic patient expectations or body dysmorphic disorder (BDD) — psychological screening recommended

• Pregnancy or planned pregnancy within 6 months

Blepharoplasty encompasses several distinct surgical approaches selected based on anatomy, functional versus cosmetic indication, ethnic considerations, and the degree of tissue excess or ptosis.

UPPER BLEPHAROPLASTY TECHNIQUES:

• Standard Excisional Upper Blepharoplasty: The gold-standard procedure for dermatochalasis. A precisely measured ellipse of skin (and often a conservative strip of pretarsal orbicularis oculi) is excised via a natural supratarsal crease incision using a Colorado needle electrocautery or radiofrequency (RF) device for haemostasis. Medial, central, and lateral fat compartments are conservatively addressed — over-resection of medial fat causes a hollow, skeletonised appearance. The crease is reformed with interrupted 6-0 Prolene or Vicryl sutures fixating skin to the levator aponeurosis.

• CO₂ Laser-Assisted Blepharoplasty: Fractionated or continuous-wave CO₂ laser replaces the scalpel for incision and simultaneous skin resurfacing. Offers superior haemostasis, reduced bruising, and the additional benefit of periorbital skin tightening in patients with mild rhytids. Particularly valuable in patients on low-dose aspirin who cannot discontinue antiplatelet therapy.

• Concurrent Levator Aponeurosis Advancement / Müller's Muscle-Conjunctival Resection (MMCR): In patients with concomitant ptosis (MRD1 < 2–3 mm), the levator aponeurosis is identified and advanced or plicated to the anterior tarsal surface. MMCR is a posterior-approach technique ideal for mild-to-moderate ptosis (1–3 mm) with good levator function (≥8 mm excursion) and a positive phenylephrine test. Both procedures are routinely performed simultaneously with upper blepharoplasty in high-volume oculoplastic centres in India and the UAE.

LOWER BLEPHAROPLASTY TECHNIQUES:

• Transconjunctival Lower Blepharoplasty: The preferred approach for younger patients with fat prolapse but adequate lower eyelid skin elasticity. Incision is placed on the conjunctival surface (palpebral conjunctiva, 4–5 mm below the tarsus), leaving no external scar. Fat can be directly excised or — in the more advanced fat-repositioning variant — mobilised and draped over the inferior orbital rim into the nasojugal groove (tear-trough deformity), eliminating the need for filler. Requires no skin excision.

• Transcutaneous (Subciliary) Lower Blepharoplasty: A 1–2 mm infralash incision allows access to the orbital septum for fat excision or repositioning combined with skin-muscle flap resection. Indicated in patients with significant lower lid skin laxity, festoons, or malar mounds. Carries a higher risk of lower lid malposition (ectropion) than the transconjunctival approach; concurrent lateral canthopexy or canthoplasty (e.g., tarsal strip procedure) significantly mitigates this risk and is standard practice at leading centres.

• Fat Repositioning / Structural Fat Grafting: Rather than simply removing herniated fat, experienced surgeons transpose the pre-aponeurotic fat pads beneath the orbital rim periosteum, filling the infraorbital hollow and creating a smooth lid-cheek junction. This arcus marginalis release and fat repositioning technique delivers a rejuvenated rather than operated appearance.

ADVANCED AND ADJUNCTIVE TECHNOLOGIES:

• Radiofrequency (RF) Skin Tightening (e.g., Morpheus8, Thermage Eyes): Used perioperatively to enhance skin retraction and collagen remodelling, particularly in patients with mild laxity who decline excisional surgery.

• Plasma Pen / Fibroblast Therapy: A non-incisional alternative for very mild upper lid excess in patients who decline surgery, with modest and temporary results.

• Endoscopic Brow Lift Combined with Blepharoplasty: In patients with pseudoptosis driven primarily by brow ptosis, simultaneous endoscopic temporal or full brow lift via scalp ports corrects the true anatomical culprit and reduces the amount of upper lid skin that needs to be excised, improving the aesthetic result.

• Hyaluronic Acid Filler Injection (Tear-Trough Filler): For patients with isolated tear-trough hollowing without significant fat prolapse, HA filler (e.g., Restylane Eyelight, Juvederm Volbella) is a non-surgical adjunct or alternative. Hyaluronidase reversal capability makes this a safe office procedure when performed by trained injectors.

All procedures at GAF Healthcare partner hospitals are performed under monitored anaesthesia care (MAC/local with sedation) or general anaesthesia, using temperature-controlled operating theatres, monopolar and bipolar electrocautery for precise haemostasis, and loupe magnification or operating microscopes where appropriate.

PHASE 1 — PRE-ARRIVAL (4–8 weeks before surgery):

• Step 1 — Virtual Consultation: Patient submits standardised periorbital photographs, medical history, and existing reports to GAF Healthcare's clinical coordination team. A board-certified oculoplastic or plastic surgeon conducts a secure video consultation, confirms candidacy, and proposes a personalised surgical plan.

• Step 2 — Pre-operative Workup: Blood investigations, Humphrey perimetry, Schirmer's test, TBUT, and thyroid panels are conducted locally or arranged on arrival. Results are reviewed by the surgical team.

• Step 3 — Travel & Visa Arrangement: GAF Healthcare facilitates the Indian e-Medical Visa application (processed within 72 hours for most nationalities) or UAE entry visa guidance. Flight and airport transfer are coordinated.

PHASE 2 — ARRIVAL & PRE-OPERATIVE PREPARATION (Day 0–1):

• Step 4 — Arrival and Orientation: Private airport transfer to partner hotel or hospital guest house. Welcome briefing by the GAF patient coordinator.

• Step 5 — In-Person Surgical Consultation: The operating surgeon performs a full in-person examination, confirms surgical markings and dimensions, reviews anaesthetic plan with the anaesthesiologist, and obtains informed consent. Formal pre-operative photography is documented.

• Step 6 — Pre-op Instructions: NPO (nil per os) after midnight before surgery if under general anaesthesia or deep sedation. Discontinuation of NSAIDs, aspirin, vitamin E, fish oil, and herbal supplements confirmed (minimum 10 days pre-operatively). Arnica Montana supplementation (oral, 30C homeopathic pellets or standardised extract) may be recommended to minimise bruising, per surgeon preference.

PHASE 3 — SURGICAL DAY (Day 1–2):

• Step 7 — Admission and Anaesthesia: Day-surgery admission 1–2 hours before the scheduled procedure. IV access established; prophylactic antibiotics (typically a single dose of IV cephalosporin) administered. Local anaesthesia (1–2% lidocaine with 1:100,000 epinephrine) infiltrated for precise hydrodissection and vasoconstriction, regardless of whether MAC or general anaesthesia is used.

• Step 8 — Surgery (Duration 45 minutes to 2.5 hours depending on scope): Surgical markings confirmed with patient upright. For upper blepharoplasty: crease incision, skin-muscle excision, fat management, wound closure with fine absorbable or removable sutures. For lower blepharoplasty: transconjunctival or subciliary approach, fat excision or repositioning, canthopexy if indicated. Both upper and lower procedures (four-lid blepharoplasty) can be performed in a single operative session.

• Step 9 — Immediate Post-op: Cold compresses applied. Patient monitored in recovery for 1–2 hours; discharged home or to hotel with an attendant the same day. Lubricating eye drops (preservative-free artificial tears) and antibiotic-steroid combination eye drops commenced.

PHASE 4 — EARLY RECOVERY (Days 1–7):

• Day 1–2: Significant periorbital ecchymosis (bruising) and oedema expected; peaks at 48–72 hours. Head elevation (30–45 degrees) and cold compresses (20 minutes on, 20 minutes off) are strictly maintained. Vision may be transiently blurred from lubricating ointment; this is normal.

• Day 3–5: Bruising transitions from deep purple to yellow-green. Oedema begins to subside. Oral analgesia (paracetamol ± a short course of low-dose prednisolone, per surgeon protocol) controls discomfort. Sutures (if non-absorbable) are typically removed at Day 5–7 — a painless, 5-minute clinic visit.

• Day 7: Milestone review: Suture removal, wound inspection, slit-lamp check. Most patients are camera-ready with corrective makeup at Week 2.

PHASE 5 — FIT-TO-FLY ASSESSMENT & DEPARTURE (Week 1–2):

• Day 10–14: Surgeon performs fit-to-fly assessment. Criteria: no active wound dehiscence, no corneal epithelial compromise on fluorescein staining, controlled intraocular pressure, ecchymosis substantially resolved, and patient is independent with eye drop instillation. A formal medical discharge summary and aftercare plan (for the treating ophthalmologist at home) are provided by GAF Healthcare.

• Patients are advised against rubbing the eyes during the flight, to use preservative-free artificial tears every 1–2 hours in-flight, wear UV-protective sunglasses, and avoid alcohol.

PHASE 6 — LONG-TERM RECOVERY MILESTONES:

• Week 3–4: Residual mild swelling resolves; incision lines flatten and transition from pink to pale.

• Month 2–3: Scars mature; final crease position and skin tone assessed.

• Month 6–12: Complete scar maturation. Final photographic outcome documentation. Long-term results are generally permanent for upper lid skin excision; lower lid fat repositioning results are durable for 7–15 years.